by Jason Heaviland | Feb 27, 2026
This data report presents Targeted Exposomics findings from a study investigating chemical exposure patterns linked to Alzheimer’s disease. Using highly sensitive quantitative analysis, the report outlines exposure-related biomarkers, altered chemical profiles, and...
by Jason Heaviland | Feb 27, 2026 | Uncategorized
For 20 years, genomics has promised precision medicine. And it delivered. For rare diseases and select cancers. But for most chronic conditions?
Genetics explains only a fraction of risk. Type 2 diabetes. Alzheimer’s disease. Autoimmune disorders. Metabolic syndrome....
